Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (Diluted Average): 2021-2023

Historic Shares Outstanding (Diluted Average) for Cullinan Therapeutics (CGEM) over the last 3 years, with Sep 2023 value amounting to $42.7 million.

  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) fell 8.26% to $42.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.7 million, marking a year-over-year decrease of 8.26%. This contributed to the annual value of $46.6 million for FY2022, which is 8.27% up from last year.
  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) amounted to $42.7 million in Q3 2023, which was up 6.00% from $40.3 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $46.6 million in Q4 2022 and a low of $40.3 million during Q2 2023.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $43.8 million, with a median of $43.4 million in 2021.
  • As far as peak fluctuations go, Cullinan Therapeutics' Shares Outstanding (Diluted Average) climbed by 8.27% in 2022, and later decreased by 13.09% in 2023.
  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) (Quarterly) stood at $43.1 million in 2021, then increased by 8.27% to $46.6 million in 2022, then fell by 8.26% to $42.7 million in 2023.
  • Its Shares Outstanding (Diluted Average) stands at $42.7 million for Q3 2023, versus $40.3 million for Q2 2023 and $40.7 million for Q1 2023.